Evecxia, Inc.

SEC filing

Biotechnology · Research Triangle Park, NC

Form D on EDGAR

Amount raised$4.6Msold at filing

Total offering$8M$3.4M still open

Investors in the raise97count reported to the SEC

FiledSep 29, 2025first sale Sep 15, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Jacob JacobsenExecutive Officer, Director

Elliot EhrichDirector

Allan ShawDirector

John KaiserDirector

Craig Robert SincockDirector

Executive officers, directors and promoters as listed on the Form D.